Lessons from the HPV vaccine offer insight and strategies for helping patients receiving COVID-19's dual-dose options finish their vaccination.
In a new study, infectious disease physicians engaged patients with hepatitis C and substance use disorder on how to best integrate comprehensive treatment into their lives.
The impact of such a significant decrease in HCV testing and treatment affects both the individual patients and public health as a whole.
Infectious disease investigator Nahid Bhadelia, MD says its diverse samples offer the potential to “understand what is driving disparities in COVID-19 outcomes and bridge them.”
The efficacy of treatment versus the prevalence of the condition in Black patients adds evidence to the pile that more diversity is needed in clinical trials.